Dividends CalendarEarnings Calendar
CLLS

CLLS | Cellectis SA

28.86 -0.61 (-2.16%) 
Healthcare sector
Cellectis SA
Category: Company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   France

Trade prices

  • Volume:
  • Market Cap: 1.16B
  • Prev closed: 18.65
  • Open: 18.85
  • High: 19.27
  • Low: 18.66
  • 52 week low: 7.32
  • 52 week high: 21.97
  • Dividends:No Dividends

Next ER: March 3, 2021 



Top Stories (CLLS)

    About the Company

    Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris and New York City.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 2, 2021- / -0.6- / 22.02M
    November 5, 2020-0.71 / -0.619.24M / 10.36M
    August 5, 2020-0.76 / -0.742.9M / 4.58MBeat!
    May 6, 20200.47 / -0.6451.91M / 16.23MBeat!
    March 16, 2020- / -0.74- / 4.97M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Feb 3, 2021 26.55 29.82
    29.82
    26.36
    		 510.75K -8.1%
    Feb 2, 2021 28.89 29.44
    30.08
    28.78
    		 368.20K 1.58%
    Feb 1, 2021 28.44 28.67
    28.78
    28.06
    		 314.45K 4.02%
    Jan 29, 2021 27.34 28.24
    28.62
    26.70
    		 269.11K -3.22%
    Jan 28, 2021 28.25 28.83
    30.12
    28.10
    		 252.12K 1.66%
    Jan 27, 2021 27.79 29.10
    29.57
    27.31
    		 368.68K -7.71%
    Jan 26, 2021 30.11 31.50
    32.25
    29.59
    		 222.96K -3.8%
    Jan 25, 2021 31.30 30.75
    31.61
    30.05
    		 231.75K 0.10%
    Jan 22, 2021 31.27 31.44
    32.05
    30.83
    		 249.42K -1.11%
    Jan 21, 2021 31.62 33.43
    33.45
    31.30
    		 349.87K -4.44%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1999
    • Employees:122

    News

    News for (CLLS)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  André Choulika, PhD

    Talk about Cellectis SA below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Mar 3, 2021 (Same day)

    clls dltr anf cpb nav omi abm splk mrvl gwre bldp snow 


    Jump to (Finance sites)

    Google     
             

    Research 


    Investor page

    www.cellectis.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInYoutube

    Peers / Similar stocks 

    xlv regn 

    Other stocks 

    baba bac wfc jpm jwn chl bks kr kss len keys mrvl 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis